Raltegravir
ISENTRESS
NADAC/unit
$34.5623
No Shortage
Tier 1: 89.7%
1 Manufacturers
1 ANDAs
ISENTRESS® is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (HIV-1) infection in patients 4 weeks of age and older.
vs. brand ISENTRESS: Generic saves up to -246% per unit
Generic Manufacturers
LUPIN LTDMERCK SHARP AND DOHME LLC A SUB OF MERCK AND CO INC
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.